Sarah Hocking

Sarah Hocking is a highly experienced Senior Formulation Scientist with a strong background in pharmaceutical sciences, holding a Master of Science from Northeastern University. Currently employed at MapLight Therapeutics, Inc., Sarah has previously held senior formulation roles at Lyndra Therapeutics and Finch Therapeutics. With extensive expertise in quality by design (QbD) approaches, Sarah has led projects involving drug-device combinations, optimized granulation and tableting processes, and conducted formulation development for clinical materials. Sarah has a solid foundation in product development, having contributed to research and manufacturing campaigns at various biopharmaceutical companies, including TARIS Biomedical and Cubist Pharmaceuticals.